businessTheravance Biopharma price target raised to $25 by BTIG on China approval Author4 hours ago01 mins Theravance Biopharma price target raised to $25 by BTIG on China approval Source link Post navigation Previous: 4-star LB Kosi Okpala projected yo TexasNext: North Korean hackers are hijacking Zoom calls to steal your crypto with scripts buried 10,000 lines deep Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment.
